The Impact of the New National Bone Health Alliance (NBHA) Diagnostic Criteria on the Prevalence of Osteoporosis in the USA
Overview
Orthopedics
Affiliations
Purpose: The purpose of this paper is to estimate the prevalence of osteoporosis in US adults ≥50 years using the NBHA osteoporosis diagnostic criteria.
Methods: Utilizing 2005-2008 data of the National Health and Nutrition Examination Survey (NHANES), we identified participants with osteoporosis with any one of the following: (1) femoral neck or lumbar spine T-score ≤ -2.5; (2) low trauma hip fracture irrespective of BMD or clinical vertebral, proximal humerus, pelvis, or distal forearm fracture with a T-score >-2.5 <-1.0; or (3) FRAX score at the National Osteoporosis Foundation intervention thresholds (≥3% for hip fracture or ≥20% for major osteoporotic fracture). We estimated the prevalence overall and by gender and age.
Results: Our sample included 1948 (54.3%) men and 1639 (45.7%) women. Approximately 12% were 80+ years and 21% were from racial/ethnic minority groups. We estimated that 16.0% (0.8) of men and 29.9% (1.0) of women 50+ years have osteoporosis. The prevalence increases with age to 46.3% in men and 77.1% in women 80+ years. The combination of FRAX score and fractures was the largest contributing factor defining osteoporosis in men (70-79, 88.1%; 80+, 80.1%), whereas T-score was the largest contributing factor in women (70-79, 49.2%; 80+, 43.5%).
Conclusions: We found that 16% of men and 29.9% of women 50+ have osteoporosis based on the NBHA diagnostic criteria. Although the expanded definition increases the prevalence compared to BMD alone-based definitions, it may better identify those at elevated fracture risk in order to reduce the burden of fractures in older adults.
Osteoporosis in Older Men: Informing Patient Management and Improving Health-Related Outcomes.
Ruggiero C, Caffarelli C, Calsolaro V, Tafaro L, Riuzzi F, Bubba V Drugs Aging. 2025; 42(1):21-38.
PMID: 39775765 DOI: 10.1007/s40266-024-01163-4.
Ma H, Zhang R, Zhou L, Wang Y, Wang J, Shen C Eur Radiol. 2024; .
PMID: 39699672 DOI: 10.1007/s00330-024-11292-4.
Gou Y, Xie X, Yin H, Wu Y, Wen Y, Zhang Y Immun Inflamm Dis. 2024; 12(11):e70047.
PMID: 39508685 PMC: 11542303. DOI: 10.1002/iid3.70047.
Lin X, Zuo Y, Hu H, Zhou J Front Genet. 2024; 15:1393106.
PMID: 39346779 PMC: 11427258. DOI: 10.3389/fgene.2024.1393106.
Wu Y, Xu Z, Dong J, Zhang W, Li J, Ji H Int J Gen Med. 2024; 17:3699-3709.
PMID: 39219673 PMC: 11363913. DOI: 10.2147/IJGM.S471924.